How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions
Cancer Immunology Immunotherapy2018Vol. 68(4), pp. 631–644
Citations Over TimeTop 10% of 2018 papers
Annika M. Bruger, Anca Dorhoi, Güneş Esendağlı, Katarzyna Barczyk‐Kahlert, Pierre van der Bruggen, Marie Lipoldová, Tomáš Perečko, Juan F. Santibáñez, Margarida Saraiva, Jo A. Van Ginderachter, Sven Brandau
Related Papers
- → CD200 and membrane protein interactions in the control of myeloid cells(2002)407 cited
- → Soluble Triggering Receptor Expressed on Myeloid Cells-1(2019)31 cited
- → High frequency of myeloid-derived suppressor cells in sepsis patients, with the granulocytic subtype dominating in Gram-positive cases(2014)6 cited
- Suppressor cells and malignancy. I. Suppressor macrophages and suppressor T cells in experimental animals.(1986)
- MiR-6991-3p is identified as a novel suppressor in the expansion and activation of myeloid-derived suppressor cells in hepatoma-bearing mice(2018)